CCNE2 and non-small cell lung carcinoma: Another investigation revealed that miR-144 could elevate G0/G1 phase-arrested in non-small cell lung cancer (NSCLC) cells and decrease the number S phase-arrested cells via suppression of CCNE1 and CCNE2 58.